Professor Ramon Shaban, Clinical Chair
Communicable Disease Control and Infection Prevention, Western Sydney Health Precinct
SYDNEY, AUSTRALIA
Bench Side Story continues with a Clinical Chair and Director of Communicable Disease Control and Infection Prevention at Western Sydney Local Health District,
Professor Ramon Z. Shaban, Clinical Chair and Director of Communicable Disease Control and Infection Prevention at the Western Sydney Local Health District, is the lead investigator and project director of the project which has received a 2022 MRFF (Medical Research Future Fund) Clinician Researchers – Nurse, Midwives and Allied Health grant for AUD$1.4 million.
-
Dr Kelly-Anne Masterman
RESEARCH IN BRAIN COMPUTER INTERFACE
@ SYNCHRON
MELBOURNE, VICTORIA, AUSTRALIA -
Stem cells used for age-related macular degeneration
Dr. Jenna Hall is a passionate and accomplished biologist with expertise in induced pluripotent stem cell (iPSC) culture, disease modelling, and high-throughput automated systems. She recently earned her PhD from the University of Melbourne, where her research focused on using iPSC-derived retinal pigment epithelium (RPE) cells to study age-related macular degeneration. Dr Hall’s technical skillset spans manual and automated cell reprogramming and differentiation, quantitative microscopy-based phenotyping, and large scale -omics analysis.
-
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
